Morbidly Obese Patients

1

Review clinical trials related to Morbidly Obese Patients. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Combination of COMBO Endoscopy Oropharyngeal Airway and HFNC Oxygenation in Sedated Gastrointestinal Endoscopy for Morbidly Obese Patients

Hypoxaemia during sedated gastrointestinal endoscopy exceeds 40 % in morbidly obese (BMI ≥ 35 kg m-²) patients. High-flow nasal cannula alone often fails because of persistent airway collapse. A recent innovation in this domain is the COMBO Endoscopy Oropharyngeal Airway-a multifaceted device that encompasses capnography monitoring, bite block , oxygenation support, and oropharyngeal airway management.The purpose of this study is to investigate whether the combination of the COMBO Endoscopy Oropharyngeal Airway and High-Flow Nasal Cannula oxygenation reduces the incidence of hypoxemia in this population.

Participants needed: 410
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Zhejiang UniversityUpdated: Mar 11, 2026Locations: 5
Eligibility criteria

Age ≥ 18 years. [+4]

Coagulation disorders or bleeding tendency (e.g., oral/nasal bleeding risk, muco... [+8]